1. Home
  2. APYX vs CCEL Comparison

APYX vs CCEL Comparison

Compare APYX & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APYX
  • CCEL
  • Stock Information
  • Founded
  • APYX 1982
  • CCEL 1989
  • Country
  • APYX United States
  • CCEL United States
  • Employees
  • APYX 252
  • CCEL N/A
  • Industry
  • APYX Medical/Dental Instruments
  • CCEL Managed Health Care
  • Sector
  • APYX Health Care
  • CCEL Health Care
  • Exchange
  • APYX Nasdaq
  • CCEL Nasdaq
  • Market Cap
  • APYX 42.3M
  • CCEL 53.9M
  • IPO Year
  • APYX 1987
  • CCEL 1997
  • Fundamental
  • Price
  • APYX $1.22
  • CCEL $6.55
  • Analyst Decision
  • APYX Buy
  • CCEL
  • Analyst Count
  • APYX 2
  • CCEL 0
  • Target Price
  • APYX $5.00
  • CCEL N/A
  • AVG Volume (30 Days)
  • APYX 43.3K
  • CCEL 3.6K
  • Earning Date
  • APYX 11-07-2024
  • CCEL 10-18-2024
  • Dividend Yield
  • APYX N/A
  • CCEL N/A
  • EPS Growth
  • APYX N/A
  • CCEL N/A
  • EPS
  • APYX N/A
  • CCEL N/A
  • Revenue
  • APYX $49,031,000.00
  • CCEL $31,641,636.00
  • Revenue This Year
  • APYX N/A
  • CCEL $3.70
  • Revenue Next Year
  • APYX $6.20
  • CCEL $10.57
  • P/E Ratio
  • APYX N/A
  • CCEL N/A
  • Revenue Growth
  • APYX 3.36
  • CCEL 1.93
  • 52 Week Low
  • APYX $0.97
  • CCEL $3.67
  • 52 Week High
  • APYX $3.32
  • CCEL $9.50
  • Technical
  • Relative Strength Index (RSI)
  • APYX 49.81
  • CCEL 46.16
  • Support Level
  • APYX $1.14
  • CCEL $6.16
  • Resistance Level
  • APYX $1.35
  • CCEL $7.19
  • Average True Range (ATR)
  • APYX 0.09
  • CCEL 0.32
  • MACD
  • APYX 0.01
  • CCEL 0.01
  • Stochastic Oscillator
  • APYX 55.17
  • CCEL 13.59

About APYX Apyx Medical Corporation

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from cellular processing and cryogenic storage and it derives revenue from processing and testing fees and storage segment.

Share on Social Networks: